The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 20, 2020
Filed:
Nov. 12, 2015
Applicant:
Probiocon Gmbh, Pfeffingen, CH;
Inventors:
Helmut Salih, Tübingen, DE;
Ludger Grosse-Hovest, Tübingen, DE;
Andreas Herrmann, Pfeffingen, CH;
Hans-Georg Kopp, Metzingen, DE;
Stefanie Maurer, Tübingen, DE;
Assignee:
Probiocon GmbH, Pfeffingen, CH;
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/395 (2006.01); G01N 33/574 (2006.01); A61K 38/19 (2006.01); C07K 14/705 (2006.01); C12Q 1/68 (2018.01); G01N 33/50 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
A61K 39/395 (2013.01); A61K 38/19 (2013.01); A61K 38/191 (2013.01); C07K 14/705 (2013.01); C07K 14/70578 (2013.01); C07K 16/2875 (2013.01); C12Q 1/68 (2013.01); G01N 33/5011 (2013.01); G01N 33/574 (2013.01); C07K 2317/21 (2013.01); C07K 2317/76 (2013.01); C07K 2319/30 (2013.01); G01N 2333/70575 (2013.01);
Abstract
The invention provides for a RANKL-specific antagonistic agent recognizing human platelet-expressed receptor activator of nuclear factor kappa-B ligand (pRANKL), for use in treating a cancer patient to prevent or reduce premetastatic lesions in blood.